Trade Puma Biotechnology, Inc. - PBYI stock price

10.6704
+0.03%
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
White Paper Declaration

PBYI price history

Date Close Change Chg% Open Min. Max.
2022-09-30 10.4596 0.4566 4.56 10.003 10.003 10.608
2022-09-30 10.1525 0.2889 2.93 9.8636 9.8636 10.3307
2022-09-30 10.0237 -0.0179 -0.18 10.0416 9.9738 10.2911
2022-09-30 10.2317 0.1491 1.48 10.0826 10.0825 10.3902
2022-09-30 10.2218 0.3964 4.03 9.8254 9.7263 10.2416
2022-09-30 9.9048 0.2981 3.10 9.6067 9.3402 9.9048
2022-09-30 9.7266 0.3667 3.92 9.3599 9.2302 9.8653
2022-09-30 9.3799 -0.1478 -1.55 9.5277 9.3303 9.5577
2022-09-30 9.5582 0.5070 5.60 9.0512 9.0512 9.6572
2022-09-30 9.37 -0.3155 -3.26 9.6855 9.37 9.8849
2022-09-30 9.6968 0.1105 1.15 9.5863 9.5863 9.9939
2022-09-30 9.8553 0.2289 2.38 9.6264 9.6264 9.9841
2022-09-30 9.7266 0.1500 1.57 9.5766 9.5766 9.7959
2022-09-30 9.7365 0.1202 1.25 9.6163 9.4491 9.786

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

Go help.dzengi.com
Dzengi Exchange
Trade BTC & tokenized stocks